Direct evidence that the N-terminal heptad repeat of Sendai virus fusion protein participates in membrane fusion

Journal of Molecular Biology

Volumn 292, Issue 3, 1999, Pages 531-546

  Ghosh, Jimut Kanti ^a   Shai, Yechiel ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Flourescence; Fusion peptide; Heptad repeat; Mechanism of membrane fusion; Sendai virus fusion protein

Indexed keywords

HEMAGGLUTININ; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLGLYCEROL; VIRUS ENVELOPE PROTEIN; VIRUS FUSION PROTEIN;

ARTICLE; CIRCULAR DICHROISM; CONFORMATIONAL TRANSITION; ERYTHROCYTE; FLUORESCENCE; HEMOLYSIS; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; MEMBRANE FUSION; PRIORITY JOURNAL; SENDAI VIRUS; VIRION; VIRUS INFECTION;

EID: 0033600718     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1999.3097     Document Type: Article

References (95)

1. Baker K. A., Dutch R. E., Lamb R. A., Jardetzky T. S. Structural basis for paramyxovirus-mediated membrane fusion. Mol. Cell. 3:1999;309-319.
2. Bartlett G. R. Phosphorous assay in column chromatography. J. Biol. Chem. 234:1959;466-468.
3. Ben-Efraim I., Kliger Y., Hermesh C., Shai Y. Membrane-induced step in the activation of Sendai virus fusion protein. J. Mol. Biol. 285:1999;609-625.
4. Bernstein H. B., Tucker S. P., Kar S. R., McPherson D. T., Dubay J. W., Lebowitz J., Compans R. W., Hunter E. Oligomerization of the hydrophobic heptad repeat of gp41. J. Virol. 69:1995;2745-2750.
5. Blumenthal R. Membrane fusion. Curr. Top. Membr. Transp. 29:1987;203-254.
6. Bosch M. L. Identification of the fusion peptide of primate immunodeficiency viruses. Science. 244:1989;694-696.
7. Brasseur R., Vandenbranden M., Cornet B., Burny A., Ruysschaert J. M. Orientation into the lipid bilayer of an asymmetric amphipathic helical peptide located at the N terminus of viral fusion proteins. Biochim. Biophys. Acta, 1029:1990;267-273.
8. Brauner J. W., Mendelson R., Prendergast F. G. Attenuated total reflectance fourier transform infrared studies of the interaction of melittin, two fragments of melittin, and δ-hemolysin with phosphatidylcholines. Biochemistry. 26:1987;8151-8158.
9. Buckland R., Malvoisin E., Beauverger P., Wild F. A leucine zipper structure present in the measles virus fusion protein is not required for its tetramerization but is essential for fusion. J. Gen. Virol. 73:1992;1703-1707.
10. Chambers P., Pringle C. R., Easton A. J. Sequence analysis of gene encoding the fusion glycoprotein of pneumonia virus of mice suggests possible conserved secondary structure elements in paramyxovirus fusion glycoproteins. J. Gen. Virol. 73:1992;1717-1724.
11. Chan D. C., Fass D., Berger J. M., Kim P. S. Core structure of gp41 the HIV envelope protein. Cell. 89:1997;263-273.
12. Chen S. S., Lee C. N., Lee W. R., McIntosh K., Lee T. H. Mutational analysis of the leucine zipper-like motif of the human immunodeficiency virus type 1 envelope transmembrane glycoprotein. J. Virol. 67:1993;3615-3619.
13. Chen S. S., Lee S. F., Hao H. J., Chuang C. K. Mutations in the leucine zipper-like heptad repeat sequence of human immunodeficiency virus type 1 gp41 dominantly interfere with wild-type virus infectivity. J. Virol. 72:1998;4765-4774.
14. Collins P. L., Chanock R. M., Mcintosh K. Fields B. N., Knipe D. M., Howley P. M. Fields Virology. 1996;1205-1241 Lippincott-Raven Publishers, Philadelphia.
15. +induced membrane insertion of influenza virus hemagglutinin involves the HA2 amino terminal fusion peptide but not the coiled coil region. J. Biol. Chem. 271:1996;13417-13421.
16. Duzgunes N., Allen T. M., Fedor J., Papahadjopoulos D. Lipid mixing during membrane aggregation and fusion: why fusion assays disagree. Biochemistry. 26:1987;8435-8442.
17. Epand R. F., Macosko J. C., Russell C. J., Shin Y. K., Epand R. M. The ectodomain of HA2 of influenza virus promotes rapid pH dependent membrane fusion. J. Mol. Biol. 286:1999;489-503.
18. Freed E. O., Myers D. J., Risser R. Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41. Proc. Natl Acad. Sci. USA. 87:1990;4650-4654.
19. Freed E. O., Delwart E. L., Buchschacher G. J., Panganiban A. T. A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity. Proc. Natl Acad. Sci. USA. 89:1992;70-74.
20. Frey S., Tamm L. K. Membrane insertion and lateral diffusion of fluorescence labelled cytochrome c oxidase subunit IV signal peptide in charged and uncharged phospholipid bilayers. Biochem. J. 272:1990;713-719.
21. Frey S., Tamm L. K. Orientation of melittin in phospholipid bilayers. A polarized attenuated total reflection infrared study. Biophys. J. 60:1991;922-930.
22. Fringeli U. P, Günthard H. H. Grell E. Membrane Spectroscopy. 1981;270-332 Springer Verlag, Berline and Heidelberg.
23. Gazit E., Shai Y. Structural and functional characterization of the α-5 segment of Bacillus thuringiensis delta-endotoxin. Biochemistry. 32:1993;3429-3436.
24. Gazit E., Miller I. R., Biggin P. C., Sansom M. S. P., Shai Y. Structure and orientation of the mammalian antibacterial peptide cecropin P1 within phospholipid membranes. J. Mol. Biol. 258:1996;860-870.
25. Gething M. J., White J. M., Waterfield M. D. Purification of the fusion protein of Sendai virus: analysis of the NH2-terminal sequence generated during precursor activation. Proc. Natl Acad. Sci. USA. 75:1978;2737-2740.
26. Gething M. J., Doms R. W., York D., White J. Studies on the mechanism of membrane fusion: site-specific mutagenesis of the hemagglutinin of influenza virus. J. Cell Biol. 102:1986;11-23.
27. Ghosh J. K., Ovadia M., Shai Y. A leucine zipper motif in the ectodomain of Sendai virus fusion protein assembles in solution and in membranes and specifically binds biologically active peptides and the virus. Biochemistry. 36:1997;15451-15462.
28. Ghosh J. K., Peisajovich S. G., Ovadia M., Shai Y. Structure-function study of a heptad repeat positioned near the transmembrane domain of Sendai virus fusion protein which blocks virus-cell fusion. J. Biol. Chem. 273:1998;27182-27190.
29. Harrick N. J. Internal Reflection Spectroscopy. 1967;Inter-science, New York.
30. Hoekstra D. Membrane fusion of enveloped viruses: especially a matter of proteins. J. Bioenerg. Biomembr. 22:1990;121.
31. Homma M., Ohuchi M. Trypsin action on the growth of sendai virus in tissue culture cells. J. Virol. 12:1973;1457-1465.
32. Horth M., Lambrecht B., Khim M. C., Bex F., Thiriart C., Ruysschaert J. M., Burny A., Brasseur R. Theoretical and functional analysis of the SIV fusion peptide. EMBO J. 10:1991;2747-2755.
33. Horvath C. M., Lamb R. A. Studies on the fusion peptide of a paramyxovirus fusion glycoprotein: roles of conserved residues in cell fusion. J. Virol. 66:1992;2443-2455.
34. Hsu M. C., Scheid A., Choppin P. W. Activation of the Sendai virus fusion protein involves a conformational change with exposure of a new hydrophobic domain. J. Biol. Chem. 256:1981;3557-3563.
35. Hu X., Ray R., Compans R. W. Functional interactions between the fusion protein and hemagglutinin neuraminidase of human parainfluenza viruses. J. Virol. 66:1992;2443-2455.
36. Ishiguro R., Kimura N., Takahashi S. Orientation of fusion-active synthetic peptides in phospholipid bilayers: determination by Fourier transform infrared spectroscopy. Biochemistry. 32:1993;9792-9797.
37. Jackson M., Mantsch H. H. The use and misuse of FTIR spectroscopy in the determination of protein structure. Crit. Rev. Biochem. Mol. Biol. 30:1995;95-120.
38. Joshi S. B., Dutch R. E., Lamb R. A. A core trimer of the paramyxovirus fusion protein: parallels to influenza virus hemagglutinin and HIV-1 gp41. Virology. 248:1998;20-34.
39. Judice J. K., Tom J. Y. K., Huang W., Wrin T., Vennari J., Petropoulos C. J., McDowell R. S. Inhibition of HIV type 1. Proc. Natl Acad. Sci. USA. 94:1997;13426-13430.
40. Kennedy D. W., Rohrbach D. H., Martin G. R., Momoi T., Yamada K. M. The adhesive glycoprotein laminin is an agglutinin. J. Cell. Physiol. 114:1983;257-262.
41. Kenner R. A., Aboderin A. A. A new fluorescent probe for protein and nucleoprotein conformation. Binding of 7-(p-methoxybenzylamino)-4-nitrobenzoxadiazole to bovine trypsinogen and bacterial ribosomes. Biochemistry. 10:1971;4433-4440.
42. Kilby J. M., Hopkins S., Venetta T. M., DiMassimo B., Cloud G. A., Lee J. Y., Alldredge L., Hunter E., Lambert D., Bolognesi D., Matthews T., Johnson M. R., Nowak M. A., Shaw G. M., Saag M. S. Potent suppression of HIV-1 replication in humans by T 20, a peptide inhibitor of gp41-mediated virus entry. Nature. Med. 4:1998;1302-1307.
43. Kliger Y., Aharoni A., Rapaport D., Jones P., Blumenthal R., Shai Y. Fusion peptides derived from the HIV type 1 glycoprotein 41 associate within phospholipid membranes and inhibit cell-cell fusion: structure-function study. J. Biol. Chem. 272:1997;13496-13505.
44. Lamb R. A. Paramyxovirus fusion: a hypothesis for changes. Virology. 197:1993;1-11.
45. Lamb R. A., Kolakofsky D. Fields B. N., Knipe D. M., Howley P. M. Fields Virology. 1996;1117-1204 Lippincott-Raven Publishers, Philadelphia.
46. Lambert D. M., Barney S., Lambert A. L., Guthrie K., Medinas R., Davis D. E., Erickson T. B., Merutka G., Petteway S. R. Jr. Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. Proc. Natl Acad. Sci. USA. 93:1996;2186-2191.
47. Lawless M. K., Barney S., Guthrie K. I., Bucy T. B., Petteway S. R., Merutka G. HIV-1 membrane fusion mechanism: structural studies of the interactions between biologically active peptides from gp41. Biochemistry. 35:1996;13697-13708.
48. Lear J. D., DeGrado W. F. Membrane binding and conformational properties of peptides representing the NH2 terminus of influenza HA-2. J. Biol. Chem. 262:1987;6500-6505.
49. Lu M., Blacklow S. C., Kim P. S. A trimeric structural domain of the HIV-1 transmembrane glycoprotein. Nature Stuct. Biol. 2:1995;1075-1082.
50. Lucy J. Biological Membranes. 1982;Academic Press, London.
51. Martin I., Defrise Q. F., Mandieau V., Nielsen N. M., Saermark T., Burny A., Brasseur R., Ruysschaert J. M., Vandenbranden M. Fusogenic activity of SIV (simian immunodeficiency virus) peptides located in the GP32 NH2 terminal domain. Biochem. Biophys. Res. Commun. 175:1991;872-879.
52. Martin I., Schaal H., Scheid A., Ruysschaert J. M. Lipid membrane fusion induced by the human immunodeficiency virus type 1 gp41 N-terminal extremity is determined by its orientation in the lipid bilayer. J. Virol. 70:1996;298-304.
53. Merrifield R. B., Vizioli L. D., Boman H. G. Synthesis of the antibacterial peptide cecropin A (1-33). Biochemistry. 21:1982;5020-5031.
54. Murata M., Sugahara Y., Takahashi S., Ohnishi S. pH-dependent membrane fusion activity of a synthetic twenty amino acid peptide with the same sequence as that of the hydrophobic segment of influenza virus hemagglutinin. J. Biochem. 102:1987;957-962.
55. Nieva J. L., Nir S., Muga A., Goni F. M., Wilschut J. Interaction of the HIV-1 fusion peptide with phospholipid vesicles: different structural requirements for fusion and leakage. Biochemistry. 33:1994;3201-3209.
56. Nir S., Bentz J., Wilschut J. Mass action kinetics of phosphatidylserine vesicle fusion as monitored by coalescence of internal vesicle volumes. Biochemistry. 19:1980;6030-6036.
57. Nir S., Bentz J., Wilschut J., Duzgunes N. Aggregation and fusion of phospholipid vesicles. Prog. Surf. Sci. 13:1983;1-124.
58. Nussbaum O., Zakai N., Loyter A. Membrane-bound antiviral antibodies as receptors for Sendai virions in receptor-depleted erythrocytes. Virology. 138:1984;185-197.
59. Okada Y. Sendai virus-induced cell fusion. Methods Enzymol. 221:1993;18-41.
60. Pastrana B., Mautone A. J., Mendelsohn R. Fourier transform infrared studies of secondary structure and orientation of pulmonary surfactant SP-C and its effect on the dynamic surface properties of phospholipids. Biochemistry. 30:1991;10058-10064.
61. Pereira F. B., Goni F. M., Muga A., Nieva J. L. Permeabilization and fusion of uncharged lipid vesicles induced by the HIV-1 fusion peptide adopting an extended conformation: dose and sequence effect. Biophys. J. 73:1997;1977-1986.
62. Peretz H., Toister Z., Laster Y., Loyter A. Fusion of intact human erythrocytes and erythrocytes ghosts. J. Cell Biol. 63:1974;1-11.
63. Pouny Y., Shai Y. Interaction of D -amino acid incorporated analogues of pardaxin with membranes. Biochemistry. 31:1992;9482-9490.
64. Pritsker M., Jones P., Blumenthal R., Shai Y. A synthetic all D -amino acid peptide corresponding to the N-terminal sequence of HIV-1 gp41 recognizes the wild-type fusion peptide in the membrane and inhibits HIV-1 envelope glycoprotein-mediated cell fusion. Proc. Natl Acad. Sci. USA. 95:1998;7287-7292.
65. Rabenstein M., Shin Y. K. A peptide from the heptad repeat of human immunodeficiency virus gp41 shows both membrane binding and coiled coil formation. Biochemistry. 34:1995;13390-13397.
66. Rafalski M., Lear J. D., DeGrado W. F. Phospholipid interactions of synthetic peptides representing the N-terminus of HIV gp41. Biochemistry. 29:1990;7917-7922.
67. Rajarathnam K., Hochman J., Schindler M., Ferguson M. S. Synthesis, location, and lateral mobility of fluorescently labeled ubiquinone 10 in mitochondrial and artificial membranes. Biochemistry. 28:1989;3168-3176.
68. Rapaport D., Shai Y. Interaction of fluorescently labeled pardaxin and its analogues with lipid bilayers. J. Biol. Chem. 266:1991;23769-23775.
69. Rapaport D., Shai Y. Aggregation and organization of pardaxin in phospholipid membranes. A fluorescence energy transfer study. J. Biol. Chem. 267:1992;6502-6509.
70. Rapaport D., Shai Y. Interaction of fluorescently labeled analogues of the amino terminal fusion peptide of Sendai virus with phospholipid membranes. J. Biol. Chem. 269:1994;15124-15131.
71. Rapaport D., Ovadia M., Shai Y. A synthetic peptide corresponding to a conserved heptad repeat domain is a potent inhibitor of Sendai virus-cell fusion: an emerging similarity with functional domains of other viruses. EMBO J. 14:1995;5524-5531.
72. Reitter J. N., Sergel T., Morrison T. G. Mutational analysis of the leucine zipper motif in the Newcastle disease virus fusion protein. J. Virol. 69:1995;5995-6004.
73. Rothschild K. J., Clark N. A. Anomalous amide I infrared absorption of purple membrane. Science. 204:1979;311-312.
74. Scheid A., Choppin P. W. Identification of the biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis and infectivity by proteolytic cleavage of an inactive precursor protein of Sendai virus. Virology. 50:1974;475-490.
75. Scheid A., Choppin P. W. Two disulfide-linked polypeptide chains constitute the active F protein of paramyxoviruses. Virology. 80:1977;54-60.
76. Scheid A., Caliguiri L. A., Compans R. W., Choppin P. W. Isolation of paramyxovirus glycoproteins. Association of hemagglutinating and neuraminidase activities with larger SV5 glycoprotein. Virology. 50:1972;640.
77. Sergel T., McGinnes M. E., Peeples M. E., Morrison T. The attachment function of the Newcastle disease virus hemagglutinin-neuraminidase protein can be separated from fusion promotion by mutation. Virology. 193:1993;717-726.
78. Sergel Germano T., McQuain C., Morrison T. Mutations in the fusion peptide and heptad repeat regions of the Newcastle disease virus fusion protein block fusion. J. Virol. 68:1994;7654-7658.
79. Shai Y., Bach D., Yanovsky A. Channel formation properties of synthetic pardaxin and analogues. J. Biol. Chem. 265:1990;20202-20209.
80. Shai Y., Hadari Y. R., Finkels A. pH-dependent pore formation properties of pardaxin analogues. J. Biol. Chem. 266:1991;22346-22354.
81. Shugars D. C., Wild C. T., Greenwell T. K., Matthews T. J. Biophysical characterization of recombinant proteins expressing the leucine zipper-like domain of the human immunodeficiency virus type 1 transmembrane protein gp41. J. Virol. 70:1996;2982-2991.
82. Slepushkin V. A., Melikyan G. B., Sidorova M. S., Chumakov V. M., Andreev S. M., Manulyan R. A., Karamov E. V. Interaction of human immunodeficiency virus (HIV-1) fusion peptides with artificial lipid membranes. Biochem. Biophys. Res. Commun. 172:1990;952-957.
83. Stegmann T., Doms R. W., Helenius A. Protein-mediated membrane fusion. Rev. Biophys. Biophys. Chem. 18:1989;187-211.
84. Struck D. K., Hoekstra D., Pagano R. E. Use of resonance energy transfer to monitor membrane fusion. Biochemistry. 20:1981;4093-4099.
85. Tamm L. K., Tatulian S. A. Infrared spectroscopy of proteins and peptides in lipid bilayers. Quart. Rev. Biophys. 30:1997;365-429.
86. Weissenhorn W., Dessen A., Harrison S. C., Skehel J. J., Wiley D. C. Atomic structure of the ectodomain from HIV-1 gp41. Nature. 387:1997;426-430.
87. White J. M. Viral and cellular membrane fusion proteins. Annu. Rev. Physiol. 52:1990;75-97.
88. Wild C., Oas T., McDanal C., Bolognesi D., Matthews T. A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition. Proc. Natl Acad. Sci. USA. 89:1992;10537-10541.
89. Wild C. T., Shugars D. C., Greenwell T. K., McDanal C. B., Matthews T. J. Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 are potent inhibitors of virus infection. Proc. Natl Acad. Sci. USA. 91:1994;9770-9774.
90. Wild C., Greenwell T., Shugars D., Rimsky-Clarke L., Matthews T. The inhibitory activity of an HIV type 1 peptide correlates with its ability to interact with a leucine zipper structure. AIDS Res. Human Retroviruses. 11:1995;323-325.
91. Wu C. S. C., Ikeda K., Yang J. T. Ordered conformation of polypeptides and proteins in acidic dodecyl sulfate solution. Biochemistry. 20:1981;566-570.
92. Yamada K. M., Yamada S. S., Pastan I. The major cell surfac glycoprotein of chick embryo fibroblasts is an agglutinin. Proc. Natl Acad. Sci. USA. 72:1975;3158-3162.
93. Yang P. W., Stewart L. C., Mantsch H. H. Polarized attenuated total reflectance spectra of oriented purple membranes. Biochem. Biophys. Res. Commun. 145:1987;298-302.
94. Yu Y. G., King D. S., Shin Y.-K. Insertion of a coiled-coil peptide from influenza virus hemagglutinin into membranes. Science. 266:1994;274-276.
95. Zimmerberg J., Vogel S. S., Chernomordik L. V. Mechanisms of membrane fusion. Annu. Rev. Biophys. Biomol. Struct. 22:1993;433-466.